Coverage
-
August 27, 2018
A California federal judge on Monday signed off on $5.65 million in fees and expenses requested by attorneys representing a class of doctors that reached a $13.45 million settlement with Allergan Inc. over allegations the company cut a deal to keep a Botox competitor off the market.
9 other articles on this case.
View all »